Alzheimer's disease appears to be caused by the brain's poor elimination of a plaque component, beta-amyloid protein, rather than simply the accumulation of it, researchers from Washington University School of Medicine, St. Louis revealed in the journal Science. We already knew that beta-amyloid...
The Foundation for the National Institutes of Health's Biomarkers Consortium announced that the results of a proteomics study performed utilizing plasma samples from the Alzheimer's Disease Neuroimaging Initiative (ADNI) are ready to be shared with scientists worldwide for further analysis...
According to the Society of Actuaries, the leading cause of U.S. long-term care claims is Alzheimer's, the brain disease that renders over 5 million Americans unable to handle all the acts of daily living unaided. Who cares? Evidently President Obama does, having written a pro-active column in...
As the leading care, research and advocacy organization for Alzheimer's disease, the Alzheimer's Association® is pleased by a significant step forward in the fight against Alzheimer's disease. Today, the Association commends the Senate Health, Education, Labor and Pensions (HELP) Committee for...
An intrepid Alzheimer's Society supporter will be hotfooting his way into Wales this week as part of a sponsored 5,000 mile walk around the United Kingdom. Philip Williams, 44, is hoping to raise £100,000 by completing the epic journey around the English, Welsh and Scottish coastlines. He has...
Ashes to Ashes and Life on Mars star Dean Andrews has called for people to run with him for Alzheimer's Society at the launch of the 2011 Bupa Great Manchester Run. Dean, best known as DS Ray Carling from the hit BBC One series, is supporting Bupa's nominated charity to help them top the £1...
Alpine mountaineer and Alzheimer's disease advocate Alan Arnette will embark later this month to climb the 7 Summits, the highest peak on each continent. This ambitious year-long climbing campaign The 7 Summits Climb for Alzheimer's: Memories are Everything aims to raise awareness of the growing...
'Outnumbered' actor and comedian, Hugh Dennis, looked on glumly yesterday as Alzheimer's Society supporter and football legend Lawrie McMenemy started the 21st Bupa Great South Run in Portsmouth. Hugh's injured, but Hilary and Dee rally 1,800 Alzheimer's Society runners in the Bupa Great South...
A new study identifies a likely cause of rapid degeneration in some Alzheimer's patients. The results of this study may lead to improved treatment.
But first, let's look at the method used in this study, because that may be almost as important as a development. And for this, we will use a...
An international team of Alzheimer's disease experts, led by Washington University School of Medicine in St. Louis, has uncovered a gene variation that appears to predict the rate at which Alzheimer's disease will progress. The investigators report their findings online in the journal Public...
Newcastle actor Tony Scott George is running in the Bupa Great North Run on 19 September to raise funds for Alzheimer's Society in honour of his grandfather. Twenty-three year old Tony, from Fenham, Newcastle upon Tyne, has signed up for the iconic half marathon in memory of his granddad, John...
An editorial in the journal Lancet debates the problems of drug development for Alzheimer's disease. The feature questions why so many trials are failing at the phase 3 clinical trial stage and asks whether the animal models used prior to this are the most effective way to test the drugs. It...
All or excerpts from the following statement can be attributed to William Thies, Ph.D., Alzheimer's Association Chief Medical and Scientific Officer: The Alzheimer's Association is disappointed to learn of the negative interim results from the Phase III clinical trial of Semagacestat. People...
Researchers from the German Centre for Neurodegenerative Diseases (DZNE) and the Ludwig-Maximilians-Universität (LMU) in Munich have shown that the ADAM10 protein can inhibit the formation of beta-amyloid, which is responsible for Alzheimer's disease. ADAM10 acts like a pair of molecular...
The primary therapeutic target in Alzheimer's disease has been the beta amyloid peptide, which clusters outside cells in the brain to form sticky clumps known as plaques. Recently, more attention has been given to the tau protein, which aggregates inside the brain cells of people with...
Scientists have identified a chemical that makes new neurons grow. The substance works specifically in a part of the brain that is integral to learning and memory. The discovery, made after researchers systematically and painstakingly infused each of 1,000 different chemicals into the brains of...
High levels of vitamin E in the blood could be linked with a decreased risk for Alzheimer's disease in older age a new study has suggested. The research published in the Journal of Alzheimer's disease claims people with high levels of several Vitamin E compounds have a 45-54 per cent lower risk...
Corpulence is unhealthy! But under certain circumstances a few extra pounds can prove advantageous. People with a lower body mass index (BMI) face a greater risk of common age-related dementia progressing into Alzheimer's Disease or other forms of profound dementia. The findings are a result...
Researchers of the University of Granada have developed a new computer program that allows early diagnosis of Alzheimer's disease through processed images. This new system has enhanced successful early diagnosis of Alzheimer's disease up to 90%, which is an important progress within this area...
AFFiRiS AG's clinical Alzheimer's vaccine candidate AD02 has already progressed to phase II clinical testing. It may therefore be possible to confirm the efficacy of the vaccine as early as during 2012. Indeed the start of this efficacy study comes only five months after the completion of the...